D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (IP6) is a phosphate ester of inositol. ChemeGen 作为优秀的抑制剂、激动剂及新型生命科学试剂的供应商,致力于为广大科研、商业实验室的科学研究者提供高品质的产品与技术服务,不断促进生命科学领域的新技术发展。
inositol hexaphosphate 【化】 肌醇六磷酸; 肌醇六磷酸酯 myo epithelial cells 【医】 肌上皮细胞 phosphatidyl inositol kinase 磷脂酰肌醇激酶 相似单词 myo inositol 【化】 肌醇 keto myo inositol 酮肌醇 inositol n. 纤维醇,纤维糖,肌糖 myo 表示“肌肉”之义 myo albumose 【医】 肌蛋白ж ...
Inositol hexaphosphate (IP6) also called phytic acid is a polyphosphorylated carbohydrate naturally found in cereals, nuts, grains, and high-fiber-containing foods. It has been shown to inhibit the growth of many different tumor cell lines both in vitro and in vivo like colon, pancreas, liver,...
Nagai,Y,Funahashi,S.Phytase (myo-inositol hexaphosphate phosphohydrolase) from wheat bran.Agricultural and Biological Chemistry. 1962Nagai, Y. & Funahashi, S. (1962). Phytase (myoinositol hexaphosphate phospho- hydrolase) from wheat bran. Part 1. Purification and substrate specificity. Agr. Biol. ...
The invention relates to a composition that includes myo-inositol hexaphosphate in a form adapted to topical administration for utilisation in the treatment or prevention of a disease associated with the development of heterogeneous nucleants in a soft tissue. Said composition can be used for ...
Myoinositol-hexaphosphate-phosphohydrotase网络即肌醇六磷酸水解酶 网络释义 1. 即肌醇六磷酸水解酶 植酸酶(Phytase)即肌醇六磷酸水解酶(Myoinositol hexaphosphate phosphohydrotase),是催化植酸及植酸盐水解成肌醇 …www.3dfeed.cn|基于1 个网页© 2025 Microsoft 隐私声明和 Cookie 法律声明 广告 帮助 反馈...
MYO-INOSITOL HEXAPHOSPHATE FOR TOPICAL USE 专利内容由知识产权出版社提供 专利名称:MYO-INOSITOL HEXAPHOSPHATE FOR TOPICAL USE 发明人:GRASES FREIXEDAS, F., Uni. de Les Illes Balears,PERELLO BESTARD, J., Uni. de Les Illes Balears,ISERN AMENGUAL, B., Uni. de Les Illes Balears,PRIETO ALMIRALL...
库存:现货 可选规格 包装 500ug 1mg 5mg 10mg 数量 确认取消 ￥510-6920 包装 价格 促销价 数量 500ug ￥637.00 510.00 -+ 1mg ￥1212.00 970.00 -+ 5mg ￥4937.00 3950.00 -+ 10mg ￥8650.00 6920.00 -+ 已选0种0瓶 金额:￥0.00 首页 D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt)详情...
The invention relates to a composition that includes myo-inositol hexaphosphate in a form adapted to topical administration for utilisation in the treatment or prevention of a disease associated with the development of heterogeneous nucleants in a soft tissue. Said composition can be used for manufactu...